BDSX
$4.75
Biodesix
($.19)
(3.85%)
BDSX
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.52)
Revenue:  $7.70 Mil
Monday
Feb 14
7:45 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when BDSX reports earnings?
Beat
Meet
Miss

Where is BDSX's stock price going from here?
Up
Flat
Down
Stock chart of BDSX
Analysts
Summary of analysts' recommendations for BDSX
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. Biodesix Inc. is based in Boulder, Colorado.